DOXORUBICINE TEVA 50 mg/25 mL, solution injectable — 1 flacon(s) en verre de 25 ml
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400955948896 -
CIP7
5594889 -
CIS
69833133
What the source publishes
- Holder
- TEVA SANTE
- Active ingredients
- CHLORHYDRATE DE DOXORUBICINE
- Form
- solution injectable
- Package
- 1 flacon(s) en verre de 25 ml
- Routes
- intraveineuse, intravésicale
- Administrative status
- authorised
- Supply regime
- médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 1996-02-26
- Prescription
- Prescription or restricted
Names this record is found by
- DOXORUBICINE TEVA 50 mg/25 mL, solution injectable — 1 flacon(s) en verre de 25 ml
- DOXORUBICINE TEVA 50 mg/25 mL, solution injectable
- CHLORHYDRATE DE DOXORUBICINE
Complete source data
{
"cis": "69833133",
"cip7": "5594889",
"form": "solution injectable",
"name": "DOXORUBICINE TEVA 50 mg/25 mL, solution injectable — 1 flacon(s) en verre de 25 ml",
"cip13": "3400955948896",
"holder": "TEVA SANTE",
"routes": [
"intraveineuse",
"intravésicale"
],
"holders": [
"TEVA SANTE"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "1996-02-26",
"compositions": [
{
"name": "CHLORHYDRATE DE DOXORUBICINE",
"nature": "SA",
"strength": "50 mg",
"linkageNumber": "1",
"substanceCode": "03236",
"dosageReference": "un flacon",
"pharmaceuticalElement": "solution"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "DOXORUBICINE TEVA 50 mg/25 mL, solution injectable",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "1 flacon(s) en verre de 25 ml",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2001-01-29",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"CHLORHYDRATE DE DOXORUBICINE"
],
"authorisationProcedure": "Procédure nationale",
"prescriptionConditions": [
"médicament nécessitant une surveillance particulière pendant le traitement",
"prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
"prescription réservée aux spécialistes et services HEMATOLOGIE",
"prescription hospitalière",
"liste I",
"prescription réservée aux médecins compétents en CANCEROLOGIE"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400955948896"